Catalent
CTLT
#1478
Rank
โ‚น988.33 B
Marketcap
โ‚น5,445
Share price
0.00%
Change (1 day)
45.17%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -โ‚น105.61

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น110.65. In 2022 the company made an earnings per share (EPS) of โ‚น194.71 a decrease over its 2021 EPS that were of โ‚น280.48.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น105.61-154.24%
2022โ‚น194.71-30.58%
2021โ‚น280.4879.67%
2020โ‚น156.11114.12%
2019โ‚น72.91-15%
2018โ‚น85.7875.44%
2017โ‚น48.89-22.97%
2016โ‚น63.47-59.56%
2015โ‚น156.97282.05%
2014โ‚น41.09-378.2%
2013-โ‚น14.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น67.76-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น64.33-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น120.94 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น548.10-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA